<DOC>
	<DOC>NCT01154634</DOC>
	<brief_summary>The purpose of this study is to investigate the pharmacodynamic effect of AZD2516 in healthy male subjects.</brief_summary>
	<brief_title>Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects</brief_title>
	<detailed_description>A double-blind, randomized, placebo-controlled, two-centre, phase IIa pharmacodynamic cross-over study to assess the effect of AZD2516 on the total number of reflux episodes in healthy male volunteers.</detailed_description>
	<criteria>Provision of signed informed consent Healthy male subjects Age 1845 years, inclusive Clinically significant illness within the 2 weeks prior to the first dose of study drug History of clinically significant cardiovascular, respiratory, renal, hepatic, neurological, mental or gastrointestinal disease Need for concomitant medications during the study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Pharmacodynamic effect</keyword>
	<keyword>Reflux inhibition</keyword>
</DOC>